Breaking News Instant updates and real-time market news.

EXEL

Exelixis

$29.47

1.66 (5.97%)

11:50
12/26/17
12/26
11:50
12/26/17
11:50

$7.7M premium block in Exelixis options

$7.7M premium block in Exelixis options. The stock up 31c to $29.78 and 10K May 24 calls trade for $7.70 when bid-ask was $6.5 to 7.80. The option blocks looks tied to $772K shares and likely swapping a position in long stock with ITM Mar calls. The call buy will open the largest open interest block in the name outside of the January term. The largest OI blocks are currently Jan 21 and 35 calls, with 10.2K and 11.5K open, respectively. The new positoin in May captures earnings in early-March and May.

  • 18

    Jan

  • 25

    Jan

  • 15

    Feb

EXEL Exelixis
$29.47

1.66 (5.97%)

09/22/17
RHCO
09/22/17
NO CHANGE
RHCO
Exelixis trial likely to be continued, says SunTrust
SunTrust analyst Peter Lawson says that the trial of Exelixis' cabozantinib.in liver cancer will most likely be continued through 2018. He views this scenario as "neutral to negative" for the stock. However, he recommends buying the shares on any weakness, citing what he sees as upcoming positive catalysts, including opportunities in bladder, breast and lung, new data, "and potential revenue beats from broadening use and 1H18 label expansion." He keeps a $33 price target and a Buy rating on the shares.
10/16/17
RHCO
10/16/17
NO CHANGE
Target $35
RHCO
Buy
Cabo result better positions Exelixis as acquisition target, says SunTrust
SunTrust analyst Peter Lawson raised his price target on Exelixis (EXEL) to $35 from $33 and maintained his Buy rating, saying the latest CELESTIAL trial cabozantinib positions the treatment well against its main competitor - Bayer's (BAYRY) Regorafenib. Lawson adds that the trial result validates the expansion of cabozantinib beyond kidney cancer and better positions Exelixis as a potentially attractive M&A target.
10/16/17
PIPR
10/16/17
NO CHANGE
Target $33
PIPR
Overweight
Exelixis price target raised to $33 from $29 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Exelixis shares to $33 after the company said the Phase III Celestial trial of Cabometyx met the primary endpoint. The analyst is confident front-line approval next year will grow renal cell carcinoma product sales to $392M in 2018. He reiterates an Overweight rating on Exelixis.
10/17/17
NEED
10/17/17
NO CHANGE
Target $33
NEED
Buy
Exelixis price target raised to $33 from $30 at Needham
Needham analyst Chad Messer raised his price target on Exelixis (EXEL) to $33, noting the latest trial data for advanced renal cell carcinoma treatment, Cabozantinib, positions it for near and long term growth. Messer says the results may be sufficient to allay competitive concerns from the recently approved Bayer (BAYRY) Stivarga, as cabozantinib offers a potentially more attractive efficacy profile.

TODAY'S FREE FLY STORIES

SNPS

Synopsys

$90.29

1.05 (1.18%)

21:14
05/23/18
05/23
21:14
05/23/18
21:14
Recommendations
Synopsys analyst commentary at JPMorgan »

Synopsys benefited from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AMZN

Amazon.com

$1,601.77

19.67 (1.24%)

21:04
05/23/18
05/23
21:04
05/23/18
21:04
Periodicals
Amazon Web Services to invest in Chile as part of LatAm expansion, Reuters says »

Amazon Web Services is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

SRRK

Scholar Rock

$0.00

(0.00%)

21:01
05/23/18
05/23
21:01
05/23/18
21:01
Syndicate
Scholar Rock 5.36M share IPO priced at $14.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

KNSA

Kiniksa

$0.00

(0.00%)

21:00
05/23/18
05/23
21:00
05/23/18
21:00
Syndicate
Kiniksa 8.5M share IPO priced at $18.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

GSKY

GreenSky

$0.00

(0.00%)

20:58
05/23/18
05/23
20:58
05/23/18
20:58
Syndicate
GreenSky 38M share IPO priced at $23.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

SAIL

SailPoint

$23.30

1.29 (5.86%)

20:56
05/23/18
05/23
20:56
05/23/18
20:56
Syndicate
SailPoint 17.808M share Secondary priced at $22.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

CLPS

CLPS

$0.00

(0.00%)

20:55
05/23/18
05/23
20:55
05/23/18
20:55
Syndicate
CLPS 2M share IPO priced at $5.25 »

The deal priced between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

MDT

Medtronic

$85.29

0.305 (0.36%)

, MCK

McKesson

$146.84

0.39 (0.27%)

20:25
05/23/18
05/23
20:25
05/23/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$85.29

0.305 (0.36%)

MCK

McKesson

$146.84

0.39 (0.27%)

BBY

Best Buy

$75.73

0.255 (0.34%)

HRL

Hormel Foods

$35.82

-0.01 (-0.03%)

TTC

Toro Company

$60.32

-0.08 (-0.13%)

SAFM

Sanderson Farms

$107.13

1.19 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

BPOP

Popular

$46.94

-0.31 (-0.66%)

20:07
05/23/18
05/23
20:07
05/23/18
20:07
Hot Stocks
Popular announces early termination of FDIC shared-loss agreements »

Popular, Inc announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

20:04
05/23/18
05/23
20:04
05/23/18
20:04
Recommendations
Williams-Sonoma analyst commentary at Loop Capital »

Williams-Sonoma earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

EWY

iShares MSCI South Korea Index Fund

$74.45

0.73 (0.99%)

, SPY

SPDR S&P 500 ETF Trust

$273.37

0.8 (0.29%)

19:59
05/23/18
05/23
19:59
05/23/18
19:59
Periodicals
Breaking Periodicals news story on iShares MSCI South Korea Index Fund, SPDR S&P 500 ETF Trust, S&P 500 »

N Korea foreign ministry…

EWY

iShares MSCI South Korea Index Fund

$74.45

0.73 (0.99%)

SPY

SPDR S&P 500 ETF Trust

$273.37

0.8 (0.29%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$128.70

0.465 (0.36%)

19:39
05/23/18
05/23
19:39
05/23/18
19:39
Hot Stocks
Canadian court affirms dismissal of suit against Chevron subsidiary »

The Ontario Court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$133.49

1.31 (0.99%)

19:19
05/23/18
05/23
19:19
05/23/18
19:19
Hot Stocks
Electronic Arts CTO sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.67

-0.39 (-0.60%)

19:14
05/23/18
05/23
19:14
05/23/18
19:14
Periodicals
Carnival CEO expects China to become the largest cruise market, CNBC says »

In an interview with CNBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

PBR

Petrobras

$15.10

-0.6 (-3.82%)

19:11
05/23/18
05/23
19:11
05/23/18
19:11
Periodicals
Petrobras slashes diesel price 10% to resolve trucker protest, Reuters says »

Petrobras has opted to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$88.94

-0.24 (-0.27%)

19:05
05/23/18
05/23
19:05
05/23/18
19:05
Hot Stocks
Sarepta granted orphan status for DMD treatment golodirsen »

The FDA granted Sarepta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BZLFF

Bunzl

$0.00

(0.00%)

19:03
05/23/18
05/23
19:03
05/23/18
19:03
Downgrade
Bunzl rating change at Goldman Sachs »

Bunzl downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WUBA

58.com

$84.56

1.39 (1.67%)

19:02
05/23/18
05/23
19:02
05/23/18
19:02
Earnings
Breaking Earnings news story on 58.com »

58.com sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 10

    Sep

WUBA

58.com

$84.56

1.39 (1.67%)

19:01
05/23/18
05/23
19:01
05/23/18
19:01
Earnings
58.com reports Q1 adjusted earnings per ADS 33c, consensus 21c »

Reports Q1 revenue $393M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 10

    Sep

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

, LASR

nLight

$30.00

-1.79 (-5.63%)

18:58
05/23/18
05/23
18:58
05/23/18
18:58
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

LASR

nLight

$30.00

-1.79 (-5.63%)

SNPS

Synopsys

$90.29

1.05 (1.18%)

LB

L Brands

$34.05

0.06 (0.18%)

NTAP

NetApp

$66.61

-0.41 (-0.61%)

DGLY

Digital Ally

$2.55

-0.075 (-2.86%)

FCAU

Fiat Chrysler

$22.47

-0.155 (-0.69%)

TM

Toyota

$134.85

-0.89 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 11

    Jun

  • 12

    Jun

  • 10

    Jul

CPRT

Copart

$52.93

-0.06 (-0.11%)

18:54
05/23/18
05/23
18:54
05/23/18
18:54
Earnings
Copart reports Q3 adjusted EPS 52c, consensus 50c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

AAPL

Apple

$188.36

1.08 (0.58%)

, VLKAY

Volkswagen

$0.00

(0.00%)

18:45
05/23/18
05/23
18:45
05/23/18
18:45
Periodicals
Apple signs pact with VW over self-driving cars, NY Times says »

Apple (AAPL) has signed…

AAPL

Apple

$188.36

1.08 (0.58%)

VLKAY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.10

-0.6 (-3.82%)

18:24
05/23/18
05/23
18:24
05/23/18
18:24
Periodicals
Breaking Periodicals news story on Petrobras »

Petrobras under scrutiny…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$344.70

13.08 (3.94%)

, CMCSA

Comcast

$31.87

-0.64 (-1.97%)

18:03
05/23/18
05/23
18:03
05/23/18
18:03
Periodicals
Netflix market value now higher than Comcast, Recode says »

Netflix's (NFLX)…

NFLX

Netflix

$344.70

13.08 (3.94%)

CMCSA

Comcast

$31.87

-0.64 (-1.97%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$113.87

-0.05 (-0.04%)

18:01
05/23/18
05/23
18:01
05/23/18
18:01
Hot Stocks
Celanese to increase selling prices on acetyl intermediate products »

To raise prices on Vinyl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.